Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoichi Hiraki

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Journal of Pharmacology & Pharmacotherapeutics|April 14, 2017
Mechanism Underlying Linezolid-induced Thrombocytopenia in a Chronic Kidney Failure Mouse ModelNao Nishijo, Yasuhiro Tsuji, Kazuhisa Matsunaga, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 4, 2020
[Evaluation of Intervention by an Antimicrobial Stewardship Team for Patients with Bacteremia]Miki Odawara, Takuya Yamashina, Kenji Irie, et al.
Cancer Immunology, Immunotherapy : CII|February 28, 2023
Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective studyAiri Fujimoto, Yoshimichi Koutake, Daisuke Hisamatsu, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Journal of Pharmacology & Pharmacotherapeutics|April 14, 2017
Mechanism Underlying Linezolid-induced Thrombocytopenia in a Chronic Kidney Failure Mouse ModelNao Nishijo, Yasuhiro Tsuji, Kazuhisa Matsunaga, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 4, 2020
[Evaluation of Intervention by an Antimicrobial Stewardship Team for Patients with Bacteremia]Miki Odawara, Takuya Yamashina, Kenji Irie, et al.
Cancer Immunology, Immunotherapy : CII|February 28, 2023
Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective studyAiri Fujimoto, Yoshimichi Koutake, Daisuke Hisamatsu, et al.
Pageof 4